Midday top 10 gainers: EGLE +46%. NBG +24%. SBSA +23%. DQ +22%. GNK +19%. AEGR +19%. GLBS +17%....

Midday top 10 gainers: EGLE +46%. NBG +24%. SBSA +23%. DQ +22%. GNK +19%. AEGR +19%. GLBS +17%. SINO +17%. PRGN +16%. LWAY +16%.
Midday top 10 losers: NCT -54%. SNFCA -22%. ONTY -21%. INFI -19%. CNIT -15%. CYCC -14%. PTSX -14%. AMD -13%. BDCO -11%. TRIT -11%.
From other sites
Comments (2)
  • smaharba
    , contributor
    Comments (4) | Send Message
    NCT is NOT down 54%. NCT completed its spinoff of New Residential, and distributed one share of New Residential (NRZ) to each of its shareholders for each share they held. Between the two companies, NCT holders when the stock was at $12.20 or so may be down a few cents in aggregate, but they have NOT lost 54%. Abbott Labs was selling in the $60-$70 range before spinning off Abbvie. Today, the combined value of Abbvie and Abbott Labs is in the $82 range. You could look at Abbott when it was $72 and see now that it sells for $36 and conclude that it has lost half its value, but the stockholders who have held on to both have done quite well -- especially with reinvested dividend.
    16 May 2013, 01:17 PM Reply Like
  • Michael Bryant
    , contributor
    Comments (6941) | Send Message
    Still waiting for my (NRZ) shares. Owned (NCT) for months. Have a Scottrade.
    16 May 2013, 03:57 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs